Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP229545.RACn4tjele64_gbuG_FE2JLuKHdAkPaV1l8KmoINLtUSc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP229545.RACn4tjele64_gbuG_FE2JLuKHdAkPaV1l8KmoINLtUSc130_assertion type Assertion NP229545.RACn4tjele64_gbuG_FE2JLuKHdAkPaV1l8KmoINLtUSc130_head.
- NP229545.RACn4tjele64_gbuG_FE2JLuKHdAkPaV1l8KmoINLtUSc130_assertion description "[In adult animals, the expression of NG2 is restricted to tumor cells and angiogenic tumor vasculature, making this proteoglycan a potential target for directing therapeutic agents to relevant sites of action.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP229545.RACn4tjele64_gbuG_FE2JLuKHdAkPaV1l8KmoINLtUSc130_provenance.
- NP229545.RACn4tjele64_gbuG_FE2JLuKHdAkPaV1l8KmoINLtUSc130_assertion evidence source_evidence_literature NP229545.RACn4tjele64_gbuG_FE2JLuKHdAkPaV1l8KmoINLtUSc130_provenance.
- NP229545.RACn4tjele64_gbuG_FE2JLuKHdAkPaV1l8KmoINLtUSc130_assertion SIO_000772 10383148 NP229545.RACn4tjele64_gbuG_FE2JLuKHdAkPaV1l8KmoINLtUSc130_provenance.
- NP229545.RACn4tjele64_gbuG_FE2JLuKHdAkPaV1l8KmoINLtUSc130_assertion wasDerivedFrom befree-20140225 NP229545.RACn4tjele64_gbuG_FE2JLuKHdAkPaV1l8KmoINLtUSc130_provenance.
- NP229545.RACn4tjele64_gbuG_FE2JLuKHdAkPaV1l8KmoINLtUSc130_assertion wasGeneratedBy ECO_0000203 NP229545.RACn4tjele64_gbuG_FE2JLuKHdAkPaV1l8KmoINLtUSc130_provenance.